EDMONTON, Alberta, May
8, 2024 – PRESS RELEASE –
Aurora Cannabis Inc., a Canadian-based
leading global medical cannabis company, is proud to announce the arrival of
Aurora branded medical cannabis products to the New Zealand market. This
new line of premium dried flowers represents a significant milestone in medical
cannabis accessibility in New Zealand, an emerging market poised for growth.
The
initial product portfolio includes cultivars grown exclusively by Aurora, with
each strain meticulously bred and cultivated to address a variety of patient
needs. These carefully crafted offerings reflect Aurora's commitment to
providing prescribers and patients with unparalleled quality, potency and
therapeutic benefits.
"As
a global leader in medical cannabis, Aurora is proud to be at the forefront of
advancing patient access in New Zealand with this first and meaningful product
launch," Aurora CEO Miguel Martin said. "We are thrilled to offer
prescribers and patients premium dried flower options that embody our
dedication to opening the world to cannabis while prioritizing patient care and
well-being. We see great potential in the New Zealand market and intend to
leverage symmetry with our leadership in Australia."
Equiposa,
the first balanced dried cannabis product in the market, is a testament to
Aurora's commitment to providing diverse options to meet patient needs. This
inaugural product offering from Aurora sets a new standard for medical cannabis
in New Zealand, backed by uncompromised quality and scientific rigor. Aurora
strives to make a meaningful difference in the lives of patients across New
Zealand, empowering them to manage their health and wellness with confidence.
